Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) shares are trading lower by 11.9% to $0.19 Wednesday morning after the company announced a 1-for-20 reverse stock split.
索諾瑪製藥公司(納斯達克股票代碼:SNOA)週三上午股價下跌11.9%,至0.19美元,此前該公司宣佈以1比20的比例進行反向股票拆分。
The stock will trade on a split-adjusted basis starting August 30, 2024. This move aims to meet Nasdaq's $1.00 minimum bid price requirement. As a result, every 20 shares of Sonoma's common stock will be consolidated into one share, reducing the total outstanding shares from 20 million to 1 million.
該股票將從2024年8月30日開始按拆分調整後的基礎上交易。此舉旨在滿足納斯達克1.00美元的最低出價要求。因此,索諾瑪每20股普通股將合併爲一股,使已發行股票總額從2000萬減少到100萬。
No fractional shares will be issued; instead, shareholders will receive cash for any fractions. The authorized shares will also increase from 24 million to 50 million.
不會發行零碎股票;相反,股東將獲得任何部分的現金。授權份額也將從2400萬增加到5000萬。
Read Also: Will Nvidia Continue To Deliver? Investors Sweat Over Hyped-up Expectations And Potential Blackwell Delay Ahead Of Q2 Report
另請閱讀:Nvidia 會繼續交付嗎?在第二季度報告發布之前,投資者對大肆宣傳的預期和布萊克韋爾可能的延遲大汗淋漓地說
Should I Sell My SNOA Stock?
我應該賣出我的 SNOA 股票嗎?
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
是賣出還是持有股票在很大程度上取決於投資者的策略和風險承受能力。波段交易者可能會出售表現跑贏大盤的股票以鎖定資本收益,而長期投資者可能會在股價進一步增長的預期下渡過難關。
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
同樣,願意最大限度地減少損失的交易者可能會賣出下跌一定百分比的股票,而長期投資者則可能將其視爲以折扣價購買更多股票的機會。
Shares of Sonoma Pharmaceuticals have lost 75.9% year to date. This compares to the average annual return of -66.61%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.
迄今爲止,索諾瑪製藥的股價已下跌75.9%。相比之下,平均年回報率爲-66.61%,這意味着該股的表現低於歷史平均水平。投資者可以將股票的走勢與其歷史表現進行比較,以評估這是正常走勢還是潛在的交易機會。
For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.
如需分析工具、圖表數據和獲取獨家股票新聞,請查看 Benzinga PRO。免費試用。
SNOA has a 52-week high of $1.02 and a 52-week low of $0.12.
SNOA的52周高點爲1.02美元,52周低點爲0.12美元。